LVW Advisors LLC Boosts Stock Holdings in Chemed Co. (NYSE:CHE)

LVW Advisors LLC boosted its position in shares of Chemed Co. (NYSE:CHE) by 11.1% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 1,040 shares of the company’s stock after buying an additional 104 shares during the period. LVW Advisors LLC’s holdings in Chemed were worth $625,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Rise Advisors LLC purchased a new stake in Chemed during the 1st quarter worth approximately $26,000. GAMMA Investing LLC increased its stake in Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after buying an additional 22 shares in the last quarter. American National Bank & Trust purchased a new stake in shares of Chemed in the third quarter valued at approximately $61,000. Mather Group LLC. purchased a new stake in shares of Chemed in the first quarter valued at approximately $67,000. Finally, EntryPoint Capital LLC grew its position in shares of Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after purchasing an additional 18 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Chemed

In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of the company’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the transaction, the executive vice president now directly owns 5,990 shares in the company, valued at $3,363,864.20. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the company’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the sale, the executive vice president now owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director George J. Walsh III sold 400 shares of the company’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total value of $238,988.00. Following the sale, the director now directly owns 3,046 shares in the company, valued at $1,819,893.62. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 9,144 shares of company stock worth $5,264,839. Insiders own 3.32% of the company’s stock.

Chemed Price Performance

CHE stock opened at $589.88 on Friday. The business has a 50 day simple moving average of $580.69 and a 200-day simple moving average of $572.49. The firm has a market capitalization of $8.93 billion, a PE ratio of 31.75, a price-to-earnings-growth ratio of 2.44 and a beta of 0.44. Chemed Co. has a 1 year low of $497.36 and a 1 year high of $654.62.

Chemed (NYSE:CHE) last released its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a net margin of 12.88% and a return on equity of 29.21%. The business had revenue of $595.88 million during the quarter, compared to analyst estimates of $599.20 million. During the same quarter in the prior year, the company posted $4.71 earnings per share. The company’s revenue was up 7.6% on a year-over-year basis. On average, equities research analysts expect that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, August 12th. This is a boost from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. Chemed’s dividend payout ratio is currently 10.76%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.